Bloom, C. I., Wong, E. ., Hickman, K. ., & Elkin, S. . (2021). Influence of the first wave of COVID-19 on asthma inhaler prescriptions. NPJ Prim Care Respir Med, 31, 45. http://doi.org/10.1038/s41533-021-00260-w
Nebulizers and Vaporizers
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2023). Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 18, 231–245. http://doi.org/10.2147/copd.s389281
Halpin, D. M. G., Rothnie, K. J., Banks, V. ., Czira, A. ., Compton, C. ., Wood, R. ., … Vogelmeier, C. F. (2022). Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. Int J Chron Obstruct Pulmon Dis, 17, 2417–2429. http://doi.org/10.2147/copd.s370540
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety. Int J Chron Obstruct Pulmon Dis, 17, 1975–1986. http://doi.org/10.2147/copd.s378486
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2022). Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 17, 1781–1795. http://doi.org/10.2147/copd.s365480
Rothnie, K. J., Joksaite, S. ., Sansbury, L. B., Compton, C. ., Di Boscio, V. ., & Ismaila, A. S. (2022). Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 17, 1455–1466. http://doi.org/10.2147/copd.s338436